An Open label, Clinical Safety Study to evaluate the effectiveness of Kalimera hair oil on Human hair health for Hair Growth, Hair Strength, Hair Lustrous and Dandruff prevention

BioVein Innovations Solutions Private Limited0 个研究点目标入组 50 人开始时间: 待定最近更新: 2021年11月24日

研究概览

暂无简介。

•Male and female volunteers 18-50 years old, inclusive.
•Able to provide informed consent after risks and benefits of the study have been explained.
•Be willing to undergo all study procedures
•Ability to communicate effectively with study personnel.
•Agree to abstain from use of any hair growth affecting oral or topical medication including over the counter and herbal medications, minoxidil, finasteride or dutasteride during the course of this study; also agrees to abstain from shaving the head during the course of the study

•Women who are pregnant or lactating.
•Subjects who took any medicine which can affect the hair growth in recent 3 months.
•Subjects who have used minoxidil or any oral or topical medication including over the counter and herbal medications for the treatment of hair loss within 6 months of study screening, or finasteride or dutasteride within 12 months of study screening.
•Subjects with scalp / skin infection, history of hypersensitivity to study products which may interfere in the study.
•Received any other investigational medicinal therapy within 30 days and topical therapy within 7 days prior to screening
•Patient suffering from any active general illness or have history of any general illness.

发起方

BioVein Innovations Solutions Private Limited